Send the following on WhatsApp
Continue to ChatI liked this article on M3 India: Isatuximab, carfilzomib, and dexamethasone in relapsed multiple myeloma (IKEMA): A multicentre, open-label, randomised phase 3 trial. Have a read: https://www.m3india.in/contents/journal/isatuximab-carfilzomib-and-dexamethasone-in-relapsed-multiple-myeloma-ikema-a?utm_campaign=unset&utm_medium=share&utm_source=ref_wa